| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/18/2001 | DE19932688A1 Design von Beta-Faltblatt-Proteinen mit spezifischen Bindungseigenschaften Design of beta-sheet proteins with specific binding properties |
| 01/18/2001 | CA2801979A1 Antigenic meningococcal peptides |
| 01/18/2001 | CA2387829A1 Method for constructing full-length cdna libraries |
| 01/18/2001 | CA2385102A1 Expression vectors and methods |
| 01/18/2001 | CA2383496A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | CA2381125A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | CA2379362A1 Respiratory syncytial viruses expressing immune modulatory molecules |
| 01/18/2001 | CA2379345A1 T-cell receptor .gamma. alternate reading frame protein, (tarp) and uses thereof |
| 01/18/2001 | CA2379221A1 Molecular determinants of tropism and virulence in enteroviruses |
| 01/18/2001 | CA2379207A1 Retroviral recombination assays and uses thereof |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2379121A1 Methods and compositions for producing full length cdna libraries |
| 01/18/2001 | CA2379059A1 Mosaic infectious bursal disease virus vaccines |
| 01/18/2001 | CA2379012A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 01/18/2001 | CA2379010A1 Methods of inducing cell death |
| 01/18/2001 | CA2378989A1 Human lim domain proteins |
| 01/18/2001 | CA2378985A1 Atherosclerosis-associated genes |
| 01/18/2001 | CA2378982A1 Methods of inhibiting muscle atrophy |
| 01/18/2001 | CA2378921A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
| 01/18/2001 | CA2378875A1 Novel neisseria meningitidis compounds and anti-infection applications thereof |
| 01/18/2001 | CA2378846A1 Prostase vaccine |
| 01/18/2001 | CA2378796A1 Seripancrin |
| 01/18/2001 | CA2378786A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | CA2378763A1 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family |
| 01/18/2001 | CA2378661A1 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/18/2001 | CA2378657A1 Identification and overexpression of a dna sequence coding for 2-methyl-6-phytylhydroquinone-methyltransferase in plants |
| 01/18/2001 | CA2378653A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 01/18/2001 | CA2378616A1 Genetic testing |
| 01/18/2001 | CA2378610A1 Human eag2 |
| 01/18/2001 | CA2378567A1 Novel myxoma genes for immune modulation |
| 01/18/2001 | CA2378562A1 Method for producing oligopolysaccharides |
| 01/18/2001 | CA2378552A1 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 01/18/2001 | CA2378549A1 Enhanced expression of proteins |
| 01/18/2001 | CA2378526A1 11-arachidonate-lipoxygenase mutants |
| 01/18/2001 | CA2378515A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 01/18/2001 | CA2378501A1 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 01/18/2001 | CA2378485A1 Proliferation differentiation factor |
| 01/18/2001 | CA2378465A1 Manipulation of tissue or organ type using the notch pathway |
| 01/18/2001 | CA2378452A1 Antimicrobial peptides derived from molluscs |
| 01/18/2001 | CA2378433A1 Prophage dna sequences and their use in determining instability in lactobacilli cultures |
| 01/18/2001 | CA2378407A1 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | CA2378240A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | CA2378179A1 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | CA2378097A1 Induction of a th1-like response in vitro |
| 01/18/2001 | CA2377938A1 Methods and compositions for directed cloning and subcloning using homologous recombination |
| 01/18/2001 | CA2374009A1 Glucoamylase variant |
| 01/18/2001 | CA2373534A1 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/18/2001 | CA2348448A1 Nucleotide sequences for the tal gene |
| 01/18/2001 | CA2348365A1 Nucleotide sequences which code for the opca gene |
| 01/18/2001 | CA2339422A1 Detection of anti-hepatitis b drug resistance |
| 01/17/2001 | EP1069190A2 Method for amplification of RNA |
| 01/17/2001 | EP1069189A2 Genotyping biallelic markers |
| 01/17/2001 | EP1069188A1 Three neprilysin-like membrane metallopeptidases |
| 01/17/2001 | EP1069187A1 Mosaic Infectious Bursal Disease Virus vaccines |
| 01/17/2001 | EP1069186A1 Gene encoding desulfurases |
| 01/17/2001 | EP1069185A1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody |
| 01/17/2001 | EP1069184A1 Human anion transporter gene implicated in Salla disease and lysosomal sialic acid transport |
| 01/17/2001 | EP1069182A1 Alleviation of symptoms associated with inflammatory disease states, using antibodies to CD18 |
| 01/17/2001 | EP1069136A1 Method for the recombinant production of ribonucleoproteins |
| 01/17/2001 | EP1069135A1 Proteins having immunomodulatory activity and remedies for immunological diseases |
| 01/17/2001 | EP1069133A1 Neisseria meningitidis compounds and anti-infection applications thereof |
| 01/17/2001 | EP1069107A1 Fullerene derivatives |
| 01/17/2001 | EP1068799A2 Biological models capable of exhibiting secondary disease manifestations |
| 01/17/2001 | EP1068529A2 Methods and compounds for modulating nuclear receptor coactivator binding |
| 01/17/2001 | EP1068528A2 Tumor tissue microarrays for rapid molecular profiling |
| 01/17/2001 | EP1068524A1 Corticotropin releasing factor receptor 1-deficient mice |
| 01/17/2001 | EP1068522A1 Antigen |
| 01/17/2001 | EP1068362A1 Hepatitis c virus ns5b compositions and methods of use thereof |
| 01/17/2001 | EP1068361A1 Diagnosis of multiple sclerosis and other demyelinating diseases |
| 01/17/2001 | EP1068358A1 Oligonucleotides containing pyrazolo 3,4-d]pyrimidines for hybridization and mismatch discrimination |
| 01/17/2001 | EP1068357A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 01/17/2001 | EP1068356A1 Addressable protein arrays |
| 01/17/2001 | EP1068352A2 Nucleic acid detection method |
| 01/17/2001 | EP1068351A2 A method for obtaining a plant with a genetic lesion in a gene sequence |
| 01/17/2001 | EP1068350A1 Directed antisense libraries |
| 01/17/2001 | EP1068348A1 Method of preparing polypeptides in cell-free system and device for its realization |
| 01/17/2001 | EP1068347A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 01/17/2001 | EP1068343A1 Preparation of recombinant adenovirus carrying a rep gene of adeno-associated virus |
| 01/17/2001 | EP1068342A2 MODIFICATION OF FATTY ACID COMPOSITION IN PLANTS BY EXPRESSION OF AN $i(ASPERGILLUS NIDULANS) DELTA-9 COA DESATURASE |
| 01/17/2001 | EP1068341A1 Particle mediated transformation of soybean with glyphosate selection |
| 01/17/2001 | EP1068340A1 Method of suppressing gene expression in plants |
| 01/17/2001 | EP1068339A1 Compositions and methods for protein secretion |
| 01/17/2001 | EP1068338A2 Enhanced prodrug activation |
| 01/17/2001 | EP1068337A2 Mammalian gene encoding tolloid-like protein |
| 01/17/2001 | EP1068336A2 Membranemetalloprotease nepii |
| 01/17/2001 | EP1068335A2 Cell cycle regulatory proteins |
| 01/17/2001 | EP1068334A2 Cell cycle regulatory proteins cdc-16, dp-1, dp-2 and e2f from plants |
| 01/17/2001 | EP1068333A1 Starch r1 phosphorylation protein homologs |
| 01/17/2001 | EP1068331A1 Medicaments for inducing cytotoxic t-cells |
| 01/17/2001 | EP1068330A2 Recombinant potyvirus construct and use thereof |
| 01/17/2001 | EP1068329A2 FUSION PROTEINS OF $i(MYCOBACTERIUM TUBERCULOSIS) ANTIGENS AND THEIR USES |
| 01/17/2001 | EP1068328A1 Treatment and diagnosis of staphylococcal infections |
| 01/17/2001 | EP1068327A2 DNA IMMUNIZATION AGAINST $i(CHLAMYDIA) INFECTION |
| 01/17/2001 | EP1068326A1 Novel sequence class of genes, corresponding proteins and the use of the same |
| 01/17/2001 | EP1068325A2 Control of floral induction in plants and uses therefor |
| 01/17/2001 | EP1068324A2 Plant 1,3-beta-d-glucan synthase and brittle-1 encoding sequences |
| 01/17/2001 | EP1068323A2 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 01/17/2001 | EP1068322A1 U4, a member of the hematopoietin receptor superfamily |
| 01/17/2001 | EP1068321A2 A interleukin-1 receptor antagonist and uses thereof |
| 01/17/2001 | EP1068319A1 PEPTIDE LIGAND HAVING SPECIFIC AFFINITY FOR THE HIV1 RETROVIRUS p24 PROTEIN |